Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Angiogenesis is a balanced process controlled by pro- and anti-angiogenic molecules of which the regulation is not fully understood. Besides classical gene regulation, miRNAs have emerged as post-transcriptional regulators of angiogenesis. Furthermore, epigenetic changes caused by histone-modifying enzymes were shown to modulate angiogenesis as well. However, a possible interplay between miRNAs and histone-modulating enzymes during angiogenesis has not been described. Here we show that VEGF-mediated down-regulation of miR-101 caused pro-angiogenic effects. We found that the pro-angiogenic effects are partly mediated through reduced repression by miR-101 of the histone-methyltransferase EZH2, a member of the Polycomb group family, thereby increasing methylation of histone H3 at lysine 27 and transcriptome alterations. In vitro, the sprouting and migratory properties of primary endothelial cell cultures were reduced by inhibiting EZH2 through up-regulation of miR-101, siRNA-mediated knockdown of EZH2, or treatment with 3-Deazaneplanocin-A (DZNep), a small molecule inhibitor of EZH2 methyltransferase activity. In addition, we found that systemic DZNep administration reduced the number of blood vessels in a subcutaneous glioblastoma mouse model, without showing adverse toxicities. Altogether, by identifying a pro-angiogenic VEGF/miR-101/EZH2 axis in endothelial cells we provide evidence for a functional link between growth factor-mediated signaling, post-transcriptional silencing, and histone-methylation in the angiogenesis process. Inhibition of EZH2 may prove therapeutic in diseases in which aberrant vascularization plays a role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122 · cited 1×
“and VEGFR2 thereby causing endothelial cell survival, proliferation, and sprouting [7].”
BackgroundThe polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717 · cited 2×
“EZH2-regulated genes indicated that EZH2 can act as a bona fide oncogene that stimulates an ‘active’ cell status by trimethylating lysine 27 of histone H3 [26,40–46].”
Background
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471
Li, J., Xu, Y., Long, X.-D., Wang, W., Jiao, H.-K., Mei, Z., Yin, Q.-Q., Ma, L.-N., Zhou, A.-W., Wang, L.-S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.008 · Cited by 242
Arif, K. M. T., Elliott, E. K., Haupt, L. M., & Griffiths, L. R. (2020) · Cancers · doi:10.3390/cancers12102922 · Cited by 183
MicroRNA regulation in angiogenesis
Caporali, A., & Emanueli, C. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.06.006 · Cited by 179
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
Crea, F., Fornaro, L., Bocci, G., Sun, L., Farrar, W. L., Falcone, A., & Danesi, R. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9387-3 · Cited by 164
Sun, P., Zhang, K., Hassan, S., Zhang, X., Tang, X., Pu, H., Stetler, R. A., Chen, J., & Yin, K. (2020) · Circulation Research · doi:10.1161/circresaha.119.315886 · Cited by 154
Role of microRNAs in the modulation of diabetic retinopathy
Mastropasqua, R., Toto, L., Cipollone, F., Santovito, D., Carpineto, P., & Mastropasqua, L. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.003 · Cited by 148
Choudhury, S. R., Balasubramanian, S., Chew, Y. C., Han, B., Marquez, V. E., & Eckert, R. L. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr171 · Cited by 122
Smits, M., Wurdinger, T., van het Hof, B., Drexhage, J. A. R., Geerts, D., Wesseling, P., Noske, D. P., Vandertop, W. P., de Vries, H. E., & Reijerkerk, A. (2012) · The FASEB Journal · doi:10.1096/fj.11-202820 · Cited by 118
Self-citationFloris, I., Descamps, B., Vardeu, A., Mitić, T., Posadino, A. M., Shantikumar, S., Sala‐Newby, G. B., Capobianco, G., Mangialardi, G., Howard, L., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304730 · Cited by 119
Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma
Tsou, P., Campbell, P. L., Amin, M. A., Coit, P., Miller, S. D., Fox, D. A., Khanna, D., & Sawalha, A. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813006116 · Cited by 114
Non-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications
Filardi, T., Catanzaro, G., Mardente, S., Zicari, A., Santangelo, C., Lenzi, A., Morano, S., & Ferretti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114020 · Cited by 120
MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
Huang, C., Xiao, X., Yang, Y., Mishra, A., Liang, Y., Zeng, X., Yang, X., Xu, D., Blackburn, M. R., Henke, C. A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.805747 · Cited by 109
A highly expressed miR-101 isomiR is a functional silencing small RNA
Llorens, F., Bañez-Coronel, M., Pantano, L., del Río, J. A., Ferrer, I., Estivill, X., & Martí, E. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-104 · Cited by 101
EZH2 as a potential target in cancer therapy
McCabe, M. T., & Creasy, C. L. (2014) · Epigenomics · doi:10.2217/epi.14.23 · Cited by 97
MicroRNAs: new players in heart failure
Rigaud, V. O. C., Fernandes-Silva, M. M., Guimarães, G. V., Bacal, F., & Bocchi, E. A. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2352-y · Cited by 92
Epigenetic regulation of endothelial‐cell‐mediated vascular repair
Fraineau, S., Palii, C. G., Allan, D., & Brand, M. (2015) · FEBS Journal · doi:10.1111/febs.13183 · Cited by 82
Maleszewska, M., Vanchin, B., Harmsen, M. C., & Krenning, G. (2015) · Angiogenesis · doi:10.1007/s10456-015-9485-2 · Cited by 80
Riquelme, E. M., Suraokar, M. B., Behrens, C., Lin, H. Y., Girard, L., Nilsson, M. B., Simon, G. R., Wang, J., Coombes, K. R., Lee, J. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1916 · Cited by 81
Histone methylation and vascular biology
Wei, X., Yi, X., Zhu, X., & Jiang, D. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00826-4 · Cited by 78
Xiao, X., Senavirathna, L. K., Gou, X., Huang, C., Liang, Y., & Liu, L. (2016) · Physiological Reports · doi:10.14814/phy2.12915 · Cited by 71
Young, J. A., Ting, K. K., Li, J., Møller, T., Dunn, L., Lü, Y., Lay, A. J., Moses, J., Prado-Lourenço, L., Khachigian, L. M., et al. (2013) · Blood · doi:10.1182/blood-2012-12-473017 · Cited by 77
Ruiz, M. A., Feng, B., & Chakrabarti, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123987 · Cited by 72
miRNAs as Mediators of Drug Resistance
Haenisch, S., & Cascorbi, I. (2012) · Epigenomics · doi:10.2217/epi.12.39 · Cited by 67
The Epigenetic Regulation of Wound Healing
Lewis, C. J., Mardaryev, A. N., Sharov, A. A., Fessing, M. Y., & Botchkarev, V. A. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0522 · Cited by 66
Delgado-Olguín, P., Dang, L. T. H., He, D. X., Thomas, S., Chi, L., Sukonnik, T., Khyzha, N., Dobenecker, M., Fish, J. E., & Bruneau, B. G. (2014) · Development · doi:10.1242/dev.112607 · Cited by 62
Targeting the epigenome in in-stent restenosis: from mechanisms to therapy
Yang, X., Yang, Y., Guo, J., Meng, Y., Li, M., Yang, P., Liu, X., Aung, L. H. H., Yu, T., & Li, Y. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.01.024 · Cited by 61
MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy
Ait‐Aissa, K., Nguyen, Q. M., Gabani, M. H., Kassan, A., Kumar, S., Choi, S. K., González, A. A., Khataei, T., Sahyoun, A. M., Chen, C., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01107-3 · Cited by 59
Sakurai, T., Bilim, V. N., Ugolkov, A. V., Yuuki, K., Tsukigi, M., Motoyama, T., & Tomita, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.035 · Cited by 57
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
Hiddingh, L., Tannous, B. A., Teng, J., Tops, B. B. J., Jeuken, J. W. M., Hulleman, E., Boots‐Sprenger, S., Vandertop, W. P., Noske, D. P., Kaspers, G. J. L., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1620 · Cited by 57
Self-citationCirculatory miR-628-5p is downregulated in prostate cancer patients
Srivastava, A., Goldberger, H., Dimtchev, A., Marian, C., Soldin, O. P., Li, X., Collins, S. P., Suy, S., & Kumar, D. (2014) · Tumor Biology · doi:10.1007/s13277-014-1638-1 · Cited by 56
Chandramouli, A., Onyeagucha, B. C., Mercado-Pimentel, M. E., Stankova, L., Shahin, N. A., LaFleur, B., Heimark, R. L., Bhattacharyya, A. K., & Nelson, M. A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.3.18874 · Cited by 53
Dreger, H., Ludwig, A., Weller, A., Stangl, V., Baumann, G., Meiners, S., & Stangl, K. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.191098 · Cited by 57
MicroRNA Signature and Cardiovascular Dysfunction
Arunachalam, G., Upadhyay, R., Ding, H., & Triggle, C. R. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000178 · Cited by 59
ATYPICAL TERATOID RHABDOID TUMOUR
Bertozzi, A., Munzer, C., Fouyssac, F., André, N., Boetto, S., Leblond, P., Bourdeaut, F., Dufour, C., Deshpande, R. K., Bhat, K. G., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou065 · Cited by 50
Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy
Feng, H., Ouyang, W., Liu, J. H., Sun, Y. G., Hu, R., Huang, L., Xian, J., Jing, C. F., & Zhou, M. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20142937 · Cited by 50
Diniz, M. S., Hiden, U., Falcão‐Pires, I., Oliveira, P. J., Sobrevía, L., & Pereira, S. P. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166834 · Cited by 52
MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma
Liu, Y., Li, H., Zhao, C., & Jia, H. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3313-0 · Cited by 48
Hernández-Romero, I. A., Guerra-Calderas, L., Salgado-Albarrán, M., Maldonado-Huerta, T., & Soto‐Reyes, E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01091 · Cited by 50
Szczepanek, J., & Tretyn, A. (2023) · Biomolecules · doi:10.3390/biom13111590 · Cited by 47
MicroRNA signature and function in retinal neovascularization
Agrawal, S., & Chaqour, B. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i1.1 · Cited by 47
Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
Lee, H. W., & Choe, M. (2012) · Pathology International · doi:10.1111/pin.12001 · Cited by 44
Vella, S., Pomella, S., Leoncini, P. P., Colletti, M., Conti, B., Márquez, V. E., Strillacci, A., Roma, J. M., Gallego, S., Milano, G. M., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0107-z · Cited by 47
Targeting of cancer stem cells by inhibitors of DNA and histone methylation
Momparler, R. L., & Côté, S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1051220 · Cited by 45
Nakahara, O., Takamori, H., Iwatsuki, M., Baba, Y., Sakamoto, Y., Tanaka, H., Chikamoto, A., Horino, K., Beppu, T., Kanemitsu, K., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2068-6 · Cited by 46
Zhang, P., Yang, X., Ma, X., Ingram, D. R., Lazar, A. J., Torres, K. E., & Pollock, R. E. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0325-1 · Cited by 46
Changes in circulating microRNA levels can be identified as early as day 8 of pregnancy in cattle
Ioannidis, J., & Donadeu, F. X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174892 · Cited by 47
Epigenetic regulation of key vascular genes and growth factors
Turunen, M. P., & Yla-Herttuala, S. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr109 · Cited by 41
“repression by miR-101 of the histone-methyltransferase EZH2, a member of the Polycomb group family, thereby increasing methylation of histone H3 at lysine 27 and transcriptome alterations.(44) Further-”
BackgroundCurrent Progress for the Use of miRNAs in Glioblastoma Treatment
Tivnan, A., & McDonald, K. L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8464-0 · Cited by 43
MiRNAs in Gestational Diabetes Mellitus: Potential Mechanisms and Clinical Applications
Liu, Z., Jiang, Y., Liu, X.-Q., Yang, M., Chen, C., Zhao, B., Huang, H., & Luo, Q. (2021) · Journal of Diabetes Research · doi:10.1155/2021/4632745 · Cited by 44
MicroRNAs: um novo paradigma no tratamento e diagnóstico da insuficiência cardíaca?
Oliveira-Carvalho, V., Carvalho, V. O., Silva, M. M., Guimarães, G. V., & Bocchi, E. A. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012000400011 · Cited by 43
Mangalhara, K. C., Manvati, S., Saini, S. K., Ponnusamy, K., Agarwal, G., Abraham, S. K., & Bamezai, R. N. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.016 · Cited by 36
EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
Xu, Z., Zhang, L.-X., Gao, B., Wan, Y., Zhang, X. H., Chen, B., Wang, Y. T., Sun, N., & Fu, Y. W. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1195-5 · Cited by 35
MicroRNA-101 Inhibits Rat Cardiac Hypertrophy by Targeting Rab1a
Wei, L., Yuan, M., Zhou, R., Bai, Q., Zhang, W., Zhang, M., Huang, Y., & Shi, L. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000203 · Cited by 33
Fledderus, J., Vanchin, B., Rots, M. G., & Krenning, G. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020103 · Cited by 34
Noncoding RNAs and Their Potential Therapeutic Applications in Tissue Engineering
Li, S., Qian, T., Wang, X., Liu, J., & Gu, X. (2017) · Engineering · doi:10.1016/j.eng.2017.01.005 · Cited by 32
Lindsay, C., Kostiuk, M. A., Harris, J., O’Connell, D. A., Seikaly, H. R., & Biron, V. L. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0390-y · Cited by 29
A review of epigenetic regulation in wound healing: Implications for the future of wound care
Lewis, C. J., Stevenson, A. W., Fear, M. W., & Wood, F. M. (2020) · Wound Repair and Regeneration · doi:10.1111/wrr.12838 · Cited by 30
de la Rosa, J., Urdiciain, A., Zazpe, I., Zelaya, M. V., Mel�ndez, B., REY, J. A., Idoate, M. A., & Castresana, J. S. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4905 · Cited by 27
Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
Wang, Z., Zhao, Y., An, Z., & Li, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01491 · Cited by 27
Dreger, H., Ludwig, A., Weller, A., Baumann, G., Stangl, V., & Stangl, K. (2016) · Genomics · doi:10.1016/j.ygeno.2016.02.002 · Cited by 22
Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases
Yang, Y., Shen, H., Cao, F., Xie, L., Zhu, G.-L., Sam, N. B., Wang, D., & Pan, H. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1696309 · Cited by 22
A microRNA Link to Glioblastoma Heterogeneity
Singh, S. K., Vartanian, A., Burrell, K. E., & Zadeh, G. M. (2012) · Cancers · doi:10.3390/cancers4030846 · Cited by 21
Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review
Gautam, N., Kaur, M., & Kaur, S. (2020) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1090_19 · Cited by 20
Fernandez-Ponce, C. M., Quiroz, R. N., Pérez, A. D., Aroca, G., Bonfanti, A. C., Acosta-Hoyos, A. J., Escorcia, L. G., Agudelo, S. H., Orozco-Sánchez, C. J., Camacho, J. L. V., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01022-8 · Cited by 18
Jy, Z., Wang, X.-L., Yang, Y., Zhang, B., & Wu, Y.-B. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120937334 · Cited by 17
Sun, H., Guo, F., & Xu, L. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29624 · Cited by 16
Vanchin, B., Sol, M., Gjaltema, R. A. F., Brinker, M. G. L., Kiers, B., Pereira, A. C., Harmsen, M. C., Moonen, J.-R. A. J., & Krenning, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-97127-4 · Cited by 15
Gene and MicroRNA Transcriptional Signatures of Angiotensin II in Endothelial Cells
Mehta, J. L., Mercanti, F., Stone, A., Wang, X., Ding, Z., Romeo, F., & Khaidakov, M. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000118 · Cited by 15
Sun, P., Xu, Y., Xiong, T., Li, S., Qiu, N., Zhou, C., Wang, J., Chang, A., Chandran, U. R., & Yin, K. (2025) · Angiogenesis · doi:10.1007/s10456-025-09987-3 · Cited by 14
Narayanan, S., Loganathan, G., Mokshagundam, S. L., Hughes, M. G., Williams, S. K., & Balamurugan, A. N. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.06.018 · Cited by 13
Potential epigenetic molecular regulatory networks in ocular neovascularization
Hu, Q., Zhang, X., Sun, M., Jiang, B., Zhang, Z., & Sun, D. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.970224 · Cited by 12
Pang, J., Ye, L., Chen, Q., Wang, J., Yang, X., He, W., & Hao, L. (2020) · BioMed Research International · doi:10.1155/2020/5426971 · Cited by 12
Liu, S., Man, Y., & Zhao, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.086 · Cited by 11
RetractedFlow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician
Rosa, S. D., Iaconetti, C., Eyileten, C., Yasuda, M., Albanese, M., Polimeni, A., Sabatino, J., Sorrentino, S., Postula, M. A., & Indolfi, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020459 · Cited by 10
Epigenetic regulations on skin wound healing: implications from current researches.
Zhang, S., & Duan, E. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.07.12 · Cited by 11
Fledderus, J., Vanchin, B., Brouwer, L. A., Kuiper, T., Jongman, R. M., van Meurs, M., Harmsen, M. C., & Krenning, G. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119242 · Cited by 10
Shukla, A., Bhardwaj, U., Apoorva, Seth, P., & Singh, S. K. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03662-8 · Cited by 9
Fledderus, J., Brouwer, L. A., Kuiper, T., Harmsen, M. C., & Krenning, G. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1373279 · Cited by 9
Chandnani, N., Choudhari, V. S., Talukdar, R., Rakshit, S., Shanmugam, G., Guchait, S., Gupta, I., George, M., & Sarkar, K. (2023) · Medical Oncology · doi:10.1007/s12032-023-02053-2 · Cited by 9
Epigenetic Control of Skin Re-Epithelialization: the NF-kB/JMJD3 Connection
Odorisio, T. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.010 · Cited by 10
Genetics and pharmacogenomics of diffuse gliomas
van Thuijl, H. F., Ylstra, B., Würdinger, T., van Nieuwenhuizen, D., Heimans, J. J., Wesseling, P., & Reijneveld, J. C. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.002 · Cited by 11
Self-citationExpression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
Buchynska, L. G., Borykun, T. V., Iurchenko, N. P., Nespryadko, S. V., & Nesina, I. P. (2020) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-42-no-4.15522 · Cited by 8
The Role of miRNA in Stem Cell Pluripotency and Commitment to the Vascular Endothelial Lineage
White, K. M., Kane, N. M., Milligan, G., & Baker, A. H. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00161.x · Cited by 7
Sadat‐Ebrahimi, S., & Aslanabadi, N. (2020) · Galen Medical Journal · doi:10.31661/gmj.v9i0.1818 · Cited by 7
Liu, Y., Mo, J., Guo, Z., Zhang, J., Tang, W., Meng, X., Luo, Y., Wang, F., & Mo, Z. (2025) · Angiogenesis · doi:10.1007/s10456-025-09998-0 · Cited by 4
Sánchez, V., Harel, S., Sa’ub, A. K., Mayaki, D., & Hussain, S. N. A. (2025) · Cells · doi:10.3390/cells14020075 · Cited by 4
Izawa, K., Shirakura, K., Kakiuchi, K., Funahashi, N., Maekawa, N., Hino, N., Tanaka, T., Doi, T., & Okada, Y. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-01014 · Cited by 4
Epigenetics and Angiogenesis in Cancer
Jha, N. K., Jha, S. K., Satyaprakash, Kar, R., Rathore, D., Ambasta, R. K., & Kumar, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-24951-3_7 · Cited by 4
Epigenetic Regulation of Skin Wound Healing
Mardaryev, A. N. (2018) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-16769-5_12 · Cited by 4
Epigenetic regulation in atherosclerosis and its therapeutic potential
Santovito, D., Atzler, D., & Weber, C. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01313-8 · Cited by 3
MiR-466h-5p induces expression of myocardin with complementary promoter sequences
Luo, Y., Liang, C., Xu, Y., & Zhang, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.133 · Cited by 3
Gu, H., Chen, Q., & Li, J. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5921 · Cited by 3
Duan, Y., Wen, T., Ma, J., Chen, Y., Liang, L., Yang, Z., Zhang, P., Quan, Z., Li, M., Feng, X.-X., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123889 · Cited by 2
Activating Mutations of the EZH2 Histone Methyltransferase in Cancer
Kruger, R. G., Graves, A. P., & McCabe, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809737-3.00011-8 · Cited by 3
Atypical Teratoid Rhabdoid Tumors
Lindsay, H., & Huang, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_33 · Cited by 2
Epigenetic regulation and microRNA expression
Jurj, A. M., Zănoagă, O., Braicu, C., & Berindan‐Neagoe, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00003-0 · Cited by 2
MicroRNA Regulation of Angiogenesis
Sen, C. K., & Chan, Y. C. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1428-5_9 · Cited by 2
Franceschetti, T., & Delany, A. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405544-5.00025-3 · Cited by 2
Metadata
- Authors
- Smits, M., Mir, S. E., Nilsson, R. J. A., van der Stoop, P. M., Niers, J. M., Marquez, V. E., Cloos, J., Breakefield, X. O., Krichevsky, A. M., Noske, D. P., Tannous, B. A., & Würdinger, T.
- Affiliations
- Cancer Center Amsterdam (NL)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-01-28
- Volume
- 6
- Issue
- 1
- Pages
- e16282
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3030563
- OpenAlex
- W2025121278
- Cited by
- 118
- References
- 52
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 15 · 2019: 7 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 19 · 2013: 8 · 2012: 12
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- American Brain Tumor Association
- Vrije Universiteit Amsterdam
- KWF Kankerbestrijding
- National Cancer Institute (P01CA069246, CA069246, P50CA086355, CA 86355)
- National Institute of Neurological Disorders and Stroke (R01NS064983)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Keywords
- miR-101, EZH2, angiogenesis, endothelial cells, VEGF signaling, histone H3 lysine 27 methylation, Polycomb group proteins, microRNA regulation, DZNep, glioblastoma, post-transcriptional gene silencing, histone methylation, vascularization
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, Animals, Cells, Cultured, DNA-Binding Proteins, Histones, Humans, Methylation, Transcription Factors, Down-Regulation, Neovascularization, Physiologic, MicroRNAs, Vascular Endothelial Growth Factor A, Angiogenic Proteins, Endothelial Cells, Mice, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.